Financial News
26 October 2026 · 60 stories
Open session · 10:00 →19
18:21MKTXencor stock surges on positive cancer drug trial dataInvesting.com ↗XNCR18:05MKTXencor Catapults On 'Unprecedented,' 'Profound' Cancer DataInvestor's Business Daily ↗XNCR17:59M&ASGRY Stock Heads For Best Day In More Than 6 Years After HealthSpan Partners’ Acquisition Offer – Here’s What Investors Need To KnowStocktwits ↗SGRY17:49MKTBrazil Stocks Dive As President Lula Wins Re-ElectionInvestor's Business Daily ↗XP17:46MKTWhy StoneCo Stock Crashed TodayMotley Fool ↗STNE17:39MKTWedbush Adjusts Price Target on Xencor to $45 From $30, Maintains Outperform RatingMT Newswires ↗XNCR17:30MKTBC-Most Active StocksAssociated Press ↗CLROSGRYSPRC16:58M&ASurgery Partners Soars 46% as Bon Secours Nears $6 Billion TakeoverTIKR ↗SGRY16:53MKTStoneCo Sinks 29%, Inter & Co Down 36%, PagSeguro Down 25% on Lula’s Unexpected Election WinTIKR ↗INTRSTNEPAGS16:19MKTSector Update: Healthcare Stocks Mixed Premarket MondayMT Newswires ↗SGRYXNCR16:18MKTXP Sinks 52%, StoneCo Down 39% on Lula’s Upset Win as Bolsonaro Calls Result “Impossible to Recognize”TIKR ↗STNE16:13MKTSurgery Partners to Be Acquired by HealthSpan Partners for $5.7 BillionMT Newswires ↗SGRY15:45ERNAzitra, Inc. Announces Revitalizing Results from Ex Vivo Study of ATR-COSF Demonstrating Ability to Reduce Fine Lines and Improve Elasticity in Human SkinPR Newswire ↗AZTR15:01MKTWhy Is StoneCo Stock Tumbling On Monday?Benzinga ↗STNE14:50MKTTop Premarket DeclinersMT Newswires ↗XPINTRSTNE14:22MKTTop Premarket GainersMT Newswires ↗RENTXNCR14:06MKTBrazilian Stocks Tumble After Lula’s Shock Win. The Country’s Path Is Unworkable.Barrons.com ↗XP13:47MKTXencor Shares Rise Pre-Bell After Kidney Cancer Trial Shows 45.5% Response RateMT Newswires ↗XNCR12:56MKTSpaceX, CoreWeave, Ambev, XP, Exxon, and More Stocks That Explain Today’s MarketBarrons.com ↗XPPre-open · before 10:001
02:12MKTWhere GrafTech International Goes After A 50% DropSimply Wall St. ↗EAFSun 25 Oct4
21:35MKTGrafTech: 2 Key Takeaways for Long-Term InvestorsMotley Fool ↗EAF16:00MKTArriVent Announces Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at ESMO Congress 2026GlobeNewswire ↗AVBP14:02ERNBank Bradesco SA (BBD) (Q3 2026) Earnings Call Highlights: Resilient Profit Growth, 11. ...GuruFocus.com ↗BBD05:09M&AIs Afya (NASDAQ:AFYA) Still Undervalued Following Its Proposed Yduqs Merger?Simply Wall St. ↗AFYASat 24 Oct3
15:30ERNGrafTech International Ltd. Q3 2026 Earnings Call SummaryMoby ↗EAF15:14REGWhy ArriVent BioPharma Stock Is In Focus After Trial Failure And Legal ProbeSimply Wall St. ↗AVBP08:15ERNGrafTech (EAF) Stock Rallies While Q3 Earnings Deepen LossesSimply Wall St. ↗EAFFri 23 Oct9
23:00MKTArriVent to Present Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at the ESMO Congress 2026GlobeNewswire ↗AVBP22:05ERNWhat Banco Bradesco (BBD) Said on Its Q3 Earnings CallMarketBeat ↗BBD20:46ERNGrafTech (EAF) Q3 2026 Earnings Call TranscriptMotley Fool ↗EAF20:04MKTOric Pharmaceuticals’ Enozertinib Shows 88% Response Rate in EGFR Lung Cancer StudyMarketBeat ↗ORIC20:04ERNWhat GrafTech International (EAF) Said on Its Q3 Earnings CallMarketBeat ↗EAF12:53MKTORIC to Advance Lung Cancer Drug Candidate to Phase 3 TrialMT Newswires ↗ORIC11:02M&AAfya Maps Yduqs Merger, BRL 2.2B Synergies and Digital Health Growth at Investor DayMarketBeat ↗AFYA10:15MKTORIC® Pharmaceuticals Presents Preclinical and Translational Data to Support the Potential of Rinzimetostat to Enhance Sensitivity to Androgen Receptor Inhibition in Prostate Cancer at ESMO Congress 2026GlobeNewswire ↗ORIC10:15MKTORIC® Pharmaceuticals Presents Potential Best-in-Class Data for Enozertinib in 1L NSCLC Patients with EGFR Atypical Mutations at ESMO Congress 2026 and Plans to Advance Enozertinib into a Global Phase 3 TrialGlobeNewswire ↗ORICThu 22 Oct4
16:02MKTNeuroThera Labs Reports Positive Progress in FDA-Approved Phase IIb Clinical Trial for Tourette SyndromeNewMediaWire ↗SPRC15:55MKTSciSparc: Subsidiary NeuroThera Labs Reports Positive Progress in FDA-Approved Phase IIb Clinical Trial for Tourette SyndromeGlobeNewswire ↗SPRC00:15MKTPagSeguro Digital Ltd. (PAGS) Stock Sinks As Market Gains: Here's WhyZacks ↗PAGS00:09MKTPagseguro Digital Insider Sold Shares Worth $709,539, According to a Recent SEC FilingMT Newswires ↗PAGSWed 21 Oct1
07:26MKTORIC Stock In Focus As New Lung Cancer Trial Data Heads To ESMO 2026Simply Wall St. ↗ORICTue 20 Oct4
17:22MKTUBS Adjusts Inter & Co Price Target to $10 From $8.80, Maintains Buy RatingMT Newswires ↗INTR16:00MKTF/m Investments Launches First 30-Year TIPS ETF: RTHYBusiness Wire ↗09:11ERNStoneCo (STNE) Stock Looks Cheap Based On Its EarningsSimply Wall St. ↗STNE02:23MKTIs Inter & Co (NasdaqGS:INTR) Still Undervalued At Current Levels?Simply Wall St. ↗INTRMon 19 Oct3
15:35MKTSciSparc Shifts Focus to Agentic AI, Targeting Cybersecurity and Finance ApplicationsGlobeNewswire ↗SPRC15:01MKTArriVent Announces Cancer Cell Publication Highlighting Firmonertinib in EGFR PACC-Mutant Non-Small Cell Lung CancerGlobeNewswire ↗AVBP15:00MKTORIC® Pharmaceuticals to Host Conference Call & Webcast to Review Enozertinib Data Being Presented at ESMO Congress 2026GlobeNewswire ↗ORICSun 18 Oct1
04:13MKTNuvation Bio And 2 Penny Stocks To WatchSimply Wall St. ↗PAGSFri 16 Oct1
15:00MKTAzitra, Inc. Announces Reverse Stock SplitPR Newswire ↗AZTRThu 15 Oct3
15:00ERNNautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026GlobeNewswire ↗NAUT14:06MKTSciSparc Announces Transformation into Agentic AI-Powered Technologies, Including Cybersecurity and Finance TechnologiesGlobeNewswire ↗SPRC03:12MKT3 Brokerage Stocks Facing New Interest Rate PressureSimply Wall St. ↗XPWed 14 Oct1
23:03MKTYour Company Stock Is 40% of Your Retirement Because You Never Sold a Share. These 3 ETFs Are How You Diversify Without Dumping It All at Once24/7 Wall St. ↗Tue 13 Oct2
17:02MKTDollar Strength Builds: ETFs to Ride the Greenback RallyZacks ↗16:00MKTInter Names Alexandre Riccio as COO, Francisco Santos as Chief Growth OfficerMT Newswires ↗INTRMon 12 Oct3
23:58MKTArriVent BioPharma Doses First Patient in Phase 1 Trial of ARR-002 for Ovarian, Endometrial CancerMT Newswires ↗AVBP23:01MKTArriVent Announces First Patient Dosed with Novel Tetravalent MUC16/NaPi2b Dual Target ADC, ARR-002GlobeNewswire ↗AVBP11:24MACWhy TIP Lost Money in 2022 While Inflation Hit 9%: The Duration Trap Inside Most TIPS ETFs24/7 Wall St. ↗Sat 10 Oct1
10:36MKTWhy XP Inc. (XP) Led This Week’s Top-Performing US Stocks: What Investors Should Watch NextInsider Monkey ↗XPHeadlines link to their source · nothing here is investment advice.